Effects of serum magnesium level on mortality in maintenance hemodialysis patients
Qing LI; Xi YAO; Jianghua CHEN; Ping ZHANG.
Chinese Journal of Nephrology
; (12): 817-823, 2020.
Artículo en Zh | WPRIM | ID: wpr-871010
Documentos relacionados
Higher Serum Magnesium Is a Survival Advantage in Maintenance Hemodialysis Patients.
Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.
Serum Magnesium and Mortality in Maintenance Hemodialysis Patients.
Rehabilitación cardiovascular en amputados de miembros inferiores de causa vascular
A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients.
Hypomagnesemia Is a Risk Factor for Cardiovascular Disease- and Noncardiovascular Disease-Related Mortality in Peritoneal Dialysis Patients.
Elevated serum FGF21 is an independent predictor for adverse events in hemodialysis patients from two large centers: a prospective cohort study.
The relationship between serum magnesium levels and mortality in non-diabetic hemodialysis patients: A 10-year follow-up study.
Effect of dialytic phosphate reduction rate on mortality in maintenance hemodialysis patients: a matched case-control study.
Serum Magnesium Levels and Mortality in Japanese Maintenance Hemodialysis Patients.